Bio-Light

BioLight Life Sciences is an Israeli-based company dedicated to the discovery, development, and commercialization of innovative products in the ophthalmic field. The company operates through a portfolio of subsidiaries and investments, targeting major eye diseases such as glaucoma and dry eye syndrome. Its pipeline includes sustained-release drug delivery systems, diagnostic tests for tear film analysis, and surgical devices. BioLight is publicly traded on the Tel Aviv Stock Exchange and focuses on addressing unmet needs in eye care through both internal development and strategic partnerships. The company is led by a management team with extensive experience in the global pharmaceutical and medical device industries.